Imiquimod is a Topical Cream in the Human Prescription Drug category. It is labeled and distributed by Padagis Israel Pharmaceuticals Ltd. The primary component is Imiquimod.
Product ID | 45802-368_58495ff3-9ece-4b2d-bade-ba842d9afb8b |
NDC | 45802-368 |
Product Type | Human Prescription Drug |
Proprietary Name | Imiquimod |
Generic Name | Imiquimod |
Dosage Form | Cream |
Route of Administration | TOPICAL |
Marketing Start Date | 2010-11-09 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA078837 |
Labeler Name | Padagis Israel Pharmaceuticals Ltd |
Substance Name | IMIQUIMOD |
Active Ingredient Strength | 13 mg/.25g |
Pharm Classes | Increased Cytokine Activity [PE],Increased Cytokine Production [PE],Interferon Inducers [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2012-07-12 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA078837 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2012-07-12 |
Marketing Category | ANDA |
Application Number | ANDA078837 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2010-11-09 |
Ingredient | Strength |
---|---|
IMIQUIMOD | 12.5 mg/.25g |
SPL SET ID: | 1505cf54-37da-4b2b-9812-6ffd6a01a7c7 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0093-3133 | Imiquimod | imiquimod |
0168-0432 | imiquimod | imiquimod |
45802-368 | Imiquimod | Imiquimod |
51672-4145 | Imiquimod | Imiquimod |
51672-4174 | Imiquimod | Imiquimod |
52549-4145 | Imiquimod | Imiquimod |
63629-8818 | Imiquimod | imiquimod |
64380-773 | imiquimod | imiquimod |
68462-536 | Imiquimod | Imiquimod |
68682-272 | Imiquimod | imiquimod |
72189-084 | IMIQUIMOD | IMIQUIMOD |
99207-260 | Aldara | imiquimod |
99207-270 | Zyclara | imiquimod |
99207-271 | Zyclara | imiquimod |
99207-276 | Zyclara | imiquimod |